Bifidobacterium longum subsp. infantis (commonly referred to as B. infantis) is a key early-life probiotic predominantly found in the infant gastrointestinal tract. It plays a critical role in digestive system development, immune maturation, and gut barrier integrity.
Widely used in infant nutrition, paediatric supplements, maternal wellness, and clinical nutrition products, this strain is particularly valued for its ability to utilize human milk oligosaccharides (HMOs), supporting healthy microbiota colonization in early life.
Â
Parameter | Description |
|---|---|
Microorganism | Bifidobacterium Longum subsp. infantis |
Potency Range | 1 Billion – 50 Billion CFU/g |
Physical Form | Freeze-dried powder |
Appearance | Off-white to light beige |
Solubility | Good dispersibility |
Shelf Life | 24 months (recommended storage) |
Storage Conditions | ≤25 °C, cool & dry place |
Â
Scientifically Recognized Benefits
Â
✔ Supports healthy gut microbiota development in infants
✔ Helps maintain digestive comfort and stool regularity*
✔ Contributes to immune system maturation and balance
✔ Supports intestinal barrier integrity and gut health
✔ Suitable for pediatric, maternal, and early-life wellness formulations
Â
Functional Characteristics
Â
Early colonizer of the infant gastrointestinal tract
Efficient metabolism of human milk oligosaccharides (HMOs)
Produces beneficial organic acids supporting a healthy gut environment
Supports gut-associated lymphoid tissue (GALT) and immune development
High tolerance to acidic and bile conditions, ensuring survival in the GI tract
Â
Key Applications
Â
Infant & Pediatric Nutrition (Powders, Drops, Sachets, Ready-to-Feed Products)
Maternal & Prenatal Nutrition
Digestive & Immune Health Supplements
Synbiotic Products (combined with HMOs, GOS, FOS)
Clinical Nutrition & Functional Foods
Â
Â
Quality, Safety & Compliance
Â
✔ Manufactured in GMP & ISO-certified facilities
✔ Compliant with US FDA dietary supplement regulations
✔ Aligned with EU EFSA probiotic ingredient frameworks
✔ Suitable for GCC regulatory and import requirements
✔ Non-GMO | Gluten-free | Allergen-free
✔ Suitable for Vegetarian formulations
✔ Halal-compliant options available (for GCC markets)
Â
Available documentation
Â
Certificate of Analysis (COA)
Technical Data Sheet (TDS)
MSDS
Stability & Shelf-Life Studies
Regulatory & Origin Declarations
Â
Formulation Advantages
Â
Ideal for infant and pediatric formulations
Stable in single-strain and multi-strain blends
Compatible with prebiotics (HMOs, GOS, FOS) for synbiotic formulations
Performs well in powders, sachets, drops, and ready-to-feed products
Flexible CFU strengths for regional regulatory compliance
Â
Target Market Segments
Â
Infant & Pediatric Nutrition
Maternal & Prenatal Health
Digestive & Gut Health
Immune Support
Clinical & Functional Nutrition
Â
Why Choose Our Bifidobacterium longum subsp. infantis?
Â
✔ Human-origin, early-life probiotic strain
✔ Export-ready quality systems and documentation
✔ High stability and consistent CFU delivery
✔ Bulk ingredient & private-label supply options
✔ Strong technical and regulatory support
✔ Trusted for sensitive pediatric applications
Â
Packaging Options
Â
Aluminium foil laminated bags
Fiber drums
Customized bulk export packaging
Frequently Asked Questions
What are the benefits of Bifidobacterium longum subsp Infantis?
Bifidobacterium longum subsp. infantis supports healthy gut microbiota development in infants, digestive comfort and stool regularity, immune system maturation and intestinal barrier integrity. It efficiently metabolises human milk oligosaccharides (HMOs) and produces beneficial organic acids. SwissMedicare Probiotics supplies B. infantis freeze-dried powder at 1 to 50 billion CFU/g for paediatric, maternal and early-life formulations.
What is Bifidobacterium longum sub infantis?
Bifidobacterium longum subsp. infantis (B. infantis) is a probiotic bacterium that is an early colonizer of the infant gut. It is especially efficient at using human milk oligosaccharides (HMOs) from breast milk, supporting healthy microbiota, immune maturation and gut barrier integrity. SwissMedicare offers it as an off-white to light beige freeze-dried powder with a 24-month shelf life.
What is Bifidobacterium longum subsp?
Bifidobacterium longum subsp. refers to a subspecies of the species Bifidobacterium longum, where 'subsp.' is the abbreviation for subspecies. B. longum includes subsp. longum, common in adults, subsp. infantis, dominant in breastfed infants, and subsp. suis, found in animals. Subspecies share core genetics but differ in traits such as which carbohydrates they can digest.
What is the difference between Bifidobacterium longum and bifidobacterium infantis?
Bifidobacterium infantis is actually a subspecies of Bifidobacterium longum, officially B. longum subsp. infantis. B. infantis specialises in digesting human milk oligosaccharides and dominates the gut of breastfed infants, while B. longum subsp. longum is more common in adults and ferments plant-derived carbohydrates. SwissMedicare supplies both ingredients for infant, adult and functional nutrition formulations.
